Sven Francque full professor - fund. clinical researcher

Publications Sven Francque

Increased 1-deoxysphingolipids caused by an altered plasma alanine to serine ratio are associated with metabolic dysfunction-associated steatotic liver disease (MASLD)

Source
Metabolomics - ISSN 1573-3882-21:6 (2025) p. 1-10
Author(s)
    F. Wipfli, M.A. Lone, A. von Eckardstein, An Verrijken, Sven Francque, Joost J. Weyler, Luc Van Gaal, B. Staels, T. Hornemann

Serial measurements of NIS2+® enable monitoring disease evolution in patients with MASH : a retrospective cohort analysis

Source
Hepatology Communications - ISSN 2471-254X-9:12 (2025) p. 1-15
Author(s)
    Arun J. Sanyal, Vlad Ratziu, Yacine Hajji, Jeremy Magnanensi, Sylvie Deledicque, Zouher Majd, Dean W. Hum, Bart Staels, Margery A. Connelly, Sven Francque, Quentin M. Anstee

Real-world evidence of the effect of adjunctive semaglutide on weight change, glycemic control, and metabolic dysfunction-associated steatotic liver disease in people with type 1 diabetes

Source
Diabetes technology and therapeutics - ISSN 1520-9156- (2025) p.
Author(s)

Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration

Source
Clinical epigenetics - ISSN 1868-7075-17:1 (2025) p. 1-22
Author(s)